Literature data reveal that miR-27a may have an oncogenic role, being up-regulated in HBV-related HCC tissues and HCC cell lines [55], and promoting proliferation in liver cancer cells by diminishing TGF-β tumor suppressive activity [56]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.